87 related articles for article (PubMed ID: 20494391)
41. Residue L143 of the foot-and-mouth disease virus leader proteinase is a determinant of cleavage specificity.
Mayer C; Neubauer D; Nchinda AT; Cencic R; Trompf K; Skern T
J Virol; 2008 May; 82(9):4656-9. PubMed ID: 18305051
[TBL] [Abstract][Full Text] [Related]
42. Leaderless Medicine.
Hospital (Lond 1886); 1894 Mar; 15(390):429-430. PubMed ID: 29830964
[No Abstract] [Full Text] [Related]
43. Mutation of FMDV L
Azzinaro PA; Medina GN; Rai D; Ramirez-Medina E; Spinard E; Rodriguez-Calzada M; Zhu J; Rieder E; de Los Santos T; Díaz-San Segundo F
Front Vet Sci; 2022; 9():1028077. PubMed ID: 36387381
[TBL] [Abstract][Full Text] [Related]
44. Foot-and-Mouth Disease Virus: Molecular Interplays with IFN Response and the Importance of the Model.
Sarry M; Vitour D; Zientara S; Bakkali Kassimi L; Blaise-Boisseau S
Viruses; 2022 Sep; 14(10):. PubMed ID: 36298684
[TBL] [Abstract][Full Text] [Related]
45. Foot-and-mouth disease virus non-structural protein 2B downregulates the RLR signaling pathway
Weerawardhana A; Uddin MB; Choi JH; Pathinayake P; Shin SH; Chathuranga K; Park JH; Lee JS
Front Immunol; 2022; 13():1020262. PubMed ID: 36248821
[TBL] [Abstract][Full Text] [Related]
46. Inhibition of MAVS Aggregation-Mediated Type-I Interferon Signaling by Foot-and-Mouth Disease Virus VP3.
Ekanayaka P; Lee BH; Weerawardhana A; Chathuranga K; Park JH; Lee JS
Viruses; 2021 Sep; 13(9):. PubMed ID: 34578357
[TBL] [Abstract][Full Text] [Related]
47. Inhibition of Antiviral Innate Immunity by Foot-and-Mouth Disease Virus L
Sui C; Jiang D; Wu X; Liu S; Li F; Pan L; Cong X; Li J; Yoo D; Rock DL; Miller LC; Lee C; Du Y; Qi J
J Virol; 2021 Jul; 95(15):e0036121. PubMed ID: 33980594
[TBL] [Abstract][Full Text] [Related]
48. Foot-and-Mouth Disease Virus Evades Innate Immune Response by 3C-Targeting of MDA5.
Kim H; Kim AY; Choi J; Park SY; Park SH; Kim JS; Lee SI; Park JH; Park CK; Ko YJ
Cells; 2021 Jan; 10(2):. PubMed ID: 33572945
[TBL] [Abstract][Full Text] [Related]
49. Foot-and-mouth disease virus VP1 target the MAVS to inhibit type-I interferon signaling and VP1 E83K mutation results in virus attenuation.
Ekanayaka P; Lee SY; Herath TUB; Kim JH; Kim TH; Lee H; Chathuranga K; Chathuranga WAG; Park JH; Lee JS
PLoS Pathog; 2020 Nov; 16(11):e1009057. PubMed ID: 33232374
[TBL] [Abstract][Full Text] [Related]
50. Use of IFN-Based Biotherapeutics to Harness the Host Against Foot-And-Mouth Disease.
Medina GN; de Los Santos T; Diaz-San Segundo F
Front Vet Sci; 2020; 7():465. PubMed ID: 32851039
[TBL] [Abstract][Full Text] [Related]
51. Modification of the second translation initiation site restricts the replication of foot-and-mouth disease virus in PK-15 cells.
Yuan H; Li N; Li P; Bai X; Sun P; Bao H; Gong X; Ma X; Cao Y; Li K; Fu Y; Zhang J; Li D; Chen Y; Zhang J; Lu Z; Liu Z
Appl Microbiol Biotechnol; 2020 Oct; 104(19):8455-8466. PubMed ID: 32820373
[TBL] [Abstract][Full Text] [Related]
52. Impairment of the DeISGylation Activity of Foot-and-Mouth Disease Virus Lpro Causes Attenuation
Medina GN; Azzinaro P; Ramirez-Medina E; Gutkoska J; Fang Y; Diaz-San Segundo F; de Los Santos T
J Virol; 2020 Jun; 94(13):. PubMed ID: 32295921
[TBL] [Abstract][Full Text] [Related]
53. Genetic Determinants of Altered Virulence of Type O Foot-and-Mouth Disease Virus.
Yang F; Zhu Z; Cao W; Liu H; Wei T; Zheng M; Zhang K; Jin Y; He J; Guo J; Liu X; Zheng H
J Virol; 2020 Mar; 94(7):. PubMed ID: 31915277
[TBL] [Abstract][Full Text] [Related]
54. Proteogenomics Uncovers Critical Elements of Host Response in Bovine Soft Palate Epithelial Cells Following In Vitro Infection with Foot-And-Mouth Disease Virus.
Pfaff F; Hägglund S; Zoli M; Blaise-Boisseau S; Laloy E; Koethe S; Zühlke D; Riedel K; Zientara S; Bakkali-Kassimi L; Valarcher JF; Höper D; Beer M; Eschbaumer M
Viruses; 2019 Jan; 11(1):. PubMed ID: 30642035
[TBL] [Abstract][Full Text] [Related]
55. The Different Tactics of Foot-and-Mouth Disease Virus to Evade Innate Immunity.
Medina GN; Segundo FD; Stenfeldt C; Arzt J; de Los Santos T
Front Microbiol; 2018; 9():2644. PubMed ID: 30483224
[TBL] [Abstract][Full Text] [Related]
56. Establishment and Evaluation of a Stable Bovine Thyroid Cell Line for Investigating Foot-and-Mouth Disease Virus.
Mao R; Sun D; Yang F; Tian H; Zhu Z; Zheng H; Liu X
Front Microbiol; 2018; 9():2149. PubMed ID: 30254623
[TBL] [Abstract][Full Text] [Related]
57. Type I Interferon Induced and Antagonized by Foot-and-Mouth Disease Virus.
Ma XX; Ma LN; Chang QY; Ma P; Li LJ; Wang YY; Ma ZR; Cao X
Front Microbiol; 2018; 9():1862. PubMed ID: 30150977
[TBL] [Abstract][Full Text] [Related]
58. Molecular Mechanisms of Foot-and-Mouth Disease Virus Targeting the Host Antiviral Response.
Rodríguez Pulido M; Sáiz M
Front Cell Infect Microbiol; 2017; 7():252. PubMed ID: 28660175
[TBL] [Abstract][Full Text] [Related]
59. Differential gene expression in porcine SK6 cells infected with wild-type and SAP domain-mutant foot-and-mouth disease virus.
Ni Z; Yang F; Cao W; Zhang X; Jin Y; Mao R; Du X; Li W; Guo J; Liu X; Zhu Z; Zheng H
Virol Sin; 2016 Jun; 31(3):249-57. PubMed ID: 27097918
[TBL] [Abstract][Full Text] [Related]
60.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
